Intervention

RNS60

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

4 shown

Effect of RNS60 on the Late Phase Asthmatic Response to Allergen ChallengeNCT02422121 · 2015-04-01

Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate AsthmaNCT01511302 · 2012-06-01

Safety Study of Nebulized RNS60 to Treat Asthma.NCT01057498 · 2010-05-01

Pilot Study of RNS60 in Allergen-induced BronchoconstrictionNCT02497222

Common conditions

Leading sponsors

Revalesio Corporation4

Trial status mix

COMPLETED3

WITHDRAWN1

Phase mix

PHASE12

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.